Hemoglobin and hematocrit levels, SCD-related complications, and outcome in patients who did not receive blood transfusion during the study period
. | SS . | SC . | ||
---|---|---|---|---|
Patients | n = 19 | n = 44 | ||
Hemoglobin concentration | ||||
(Hb, g/dL, mean ± SD) | ||||
Hematocrit (Ht, mean ± SD) | Hb | Ht | Hb | Ht |
At inclusion4-150 | 7.0 ± 1.3 | 23.1 ± 4.0 | 9.2 ± 1.4 | 28.4 ± 4.5 |
Before labor | 8.2 ± 0.7 | 26.0 ± 2.7 | 9.8 ± 1.3 | 29.8 ± 4.0 |
Immediate post delivery | 6.6 ± 1.4 | 21.5 ± 4.1 | 8.8 ± 1.4 | 27.3 ± 4.0 |
Day +15 post delivery | 7.8 ± 0.9 | 25.0 ± 2.8 | 10.0 ± 1.3 | 30.6 ± 3.7 |
Patients with SCD-related pain | 8 | 19 | ||
crises (total episodes) | (12) | (26) | ||
Patients with P falciparum malaria (total episodes) | 2 (4) | 10 (15) | ||
Delivery route | ||||
Vaginal | 10 | 33 | ||
Cesarean section | 8 | 10 | ||
Spontaneous abortion | 14-151 | 1 | ||
Fetal outcome: | ||||
Stillbirth | 2‡ | 1 | ||
Live birth | 16 | 42 | ||
Maternal death | 0 | 0 |
. | SS . | SC . | ||
---|---|---|---|---|
Patients | n = 19 | n = 44 | ||
Hemoglobin concentration | ||||
(Hb, g/dL, mean ± SD) | ||||
Hematocrit (Ht, mean ± SD) | Hb | Ht | Hb | Ht |
At inclusion4-150 | 7.0 ± 1.3 | 23.1 ± 4.0 | 9.2 ± 1.4 | 28.4 ± 4.5 |
Before labor | 8.2 ± 0.7 | 26.0 ± 2.7 | 9.8 ± 1.3 | 29.8 ± 4.0 |
Immediate post delivery | 6.6 ± 1.4 | 21.5 ± 4.1 | 8.8 ± 1.4 | 27.3 ± 4.0 |
Day +15 post delivery | 7.8 ± 0.9 | 25.0 ± 2.8 | 10.0 ± 1.3 | 30.6 ± 3.7 |
Patients with SCD-related pain | 8 | 19 | ||
crises (total episodes) | (12) | (26) | ||
Patients with P falciparum malaria (total episodes) | 2 (4) | 10 (15) | ||
Delivery route | ||||
Vaginal | 10 | 33 | ||
Cesarean section | 8 | 10 | ||
Spontaneous abortion | 14-151 | 1 | ||
Fetal outcome: | ||||
Stillbirth | 2‡ | 1 | ||
Live birth | 16 | 42 | ||
Maternal death | 0 | 0 |